Citing a study from the University of Chile, which claimed that the Chinese-made vaccine from Sinovac is “not up to the appropriate standards”, the head of the Technical Experts Committee Mira Rakacolli said that the study’s methodology should be taken in consideration, and underlined that the Chinese jab “prevents mortalities at 100%”.
Euronews Albania anchor Loneta Progni, mentioned the data of the study, which suggests that the vaccine is only 3% effective after the first dose is administered, increasing to 56.5% after the second one.
The study conducted in one of the countries with the highest vaccine rollouts in the world, as Chile is being referred to, claims that the vaccine is only 27.7% effective after the injection of both doses.
The deputy minister of health said that the third phase of the vaccine trial conducted in Brazil claimed that it was 50.6% effective, meanwhile another study in Indonesia said that it was over 87% effective.
“It is the same vaccine but it depends on how the study was measured and the connotation of the “effectiveness”, therefore this is where should refer to. The effectiveness of the vaccine comes in first, in how many vaccines does it prevent death and when it comes to that, all studies show, including that of the University of Chile, that the Chinese vaccinee is effective 100%”, said Rakacolli.
YOU MIGHT ALSO LIKE
